# Immuno-ablation With Chemoimmunoradiation and Autologous Stem Cell Transplant for Churg-Strauss Syndrome

> **NCT02728271** · EARLY_PHASE1 · TERMINATED · sponsor: **Mounzer Agha** · enrollment: 1 (actual)

## Conditions studied

- Churg-Strauss Syndrome

## Interventions

- **BIOLOGICAL:** HPC cell infusion

## Key facts

- **NCT ID:** NCT02728271
- **Lead sponsor:** Mounzer Agha
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-04
- **Primary completion:** 2016-07-22
- **Final completion:** 2016-08-20
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** PI left the institution
- **Last updated:** 2017-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02728271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02728271, "Immuno-ablation With Chemoimmunoradiation and Autologous Stem Cell Transplant for Churg-Strauss Syndrome". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02728271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*